Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

34.0K
Overview
34.0K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

67
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
67
Arboviral Encephalitis01:25

Arboviral Encephalitis

43
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
43
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Viral Recombination00:57

Viral Recombination

25.8K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.8K
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

60
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Luminescent heparin-functionalized carbon dots with potential applications in nanoparticle-protein interactions and cell imaging.

Scientific reports·2026
Same author

Marine-Derived Dual BTK-FGFR Inhibitors: Pioneering a New Era of Precision Oncology Therapeutics.

Anti-cancer agents in medicinal chemistry·2026
Same author

Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology.

Personalized medicine·2026
Same author

Novel class of population mean estimators based on robust regression methods.

Scientific reports·2026
Same author

New thiazole-biaryls as small molecule immunomodulators (SMIs) targeting PD-1/PD-L1 axis.

Bioorganic & medicinal chemistry letters·2026
Same author

Unraveling the Multifunctional and Translational Paradigm of Nanoparticulate Systems against Colorectal Cancer.

ACS applied bio materials·2026
Same journal

Cross-System Transcriptomics Suggests Enterovirus A71 Exploits Wound Healing Programs to Target Neural Progenitors in Human Spinal Cord Organoids.

Infectious disorders drug targets·2026
Same journal

Harnessing the Power of Chinese Essential Oils: A Systematic Review on Holistic Approach to Acne Treatment and Anti-Aging Therapy.

Infectious disorders drug targets·2026
Same journal

Diagnosis of Skin Parasites, Bacteria, and Fungi and Their Impact on Hematological Parameters in Patients with T-LGL Leukemia.

Infectious disorders drug targets·2026
Same journal

The Effective Dosing Schedule of Sodium Bicarbonate for Improving pH in Patients with Metabolic Acidosis.

Infectious disorders drug targets·2026
Same journal

Field Cancerization of the Cervix and Vulva in a Young HIV-Positive Woman: Diagnostic Challenges in Multifocal HPV Disease - A Case Report and Literature Review.

Infectious disorders drug targets·2026
Same journal

A Randomized Clinical Trial Evaluating Antimicrobial Effectiveness of a New Licorice Oral Gel against Salivary Streptococcus mutans.

Infectious disorders drug targets·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K

Ebola virus: current and future perspectives.

Surender Singh Jadav, Anoop Kumar, Mohamed Jawed Ahsan

  • 1Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi- 835215, Jharkhand, India. drvenkatesanj@gmail.com.

Infectious Disorders Drug Targets
|April 26, 2015
PubMed
Summary
This summary is machine-generated.

This review summarizes the Ebola virus disease outbreak, its transmission, and pathogenesis. It highlights the virus

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.8K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

Related Experiment Videos

Last Updated: Apr 14, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.8K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

Area of Science:

  • Virology
  • Epidemiology
  • Immunology

Background:

  • Ebola virus disease (EVD) outbreaks, particularly in Western Africa, pose significant global health risks.
  • EVD spreads through direct contact with infected individuals or bodily fluids, leading to high fatality rates, often due to hemorrhagic fever.
  • The virus infects macrophages and endothelial cells, producing viral protein 24 (eVP24) that interferes with the immune system's interferon response.

Purpose of the Study:

  • To review the epidemiology, pathogenesis, and current treatment landscape of Ebola virus infection.
  • To explore potential therapeutic targets and promising ligands for drug development against EVD.
  • To address the knowledge gaps regarding Ebola virus' manipulation of the immune system.

Main Methods:

  • Literature review compiling existing data on Ebola virus disease.
  • Analysis of epidemiological trends and transmission patterns.
  • Examination of the pathogenesis, including viral mechanisms and host immune response.

Main Results:

  • Ebola virus infection is characterized by high pathogenicity and significant mortality rates.
  • Viral Protein 24 (eVP24) plays a role in immune evasion by inhibiting interferon signaling.
  • Understanding viral pathogenesis is crucial for developing effective treatments, as none are currently approved.

Conclusions:

  • Further research into Ebola virus' immune evasion strategies is essential.
  • Identifying and developing novel ligands and drug targets holds promise for future EVD treatments.
  • A comprehensive understanding of EVD's epidemiology and pathogenesis is vital for effective outbreak control and patient management.